People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| STAQ Pharma, Inc. | — | Pharmaceuticals | Series B | $64.9M | $74.4M | 2017 |
| Sharklet Technologies, Inc. | — | Biotechnology | Seed | $3.2M | $89.0M | 2009 |
Joseph W Bagan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Joseph W Bagan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Al Perkins | 1 | 2 |
| Scott M Hawig | 1 | 1 |
| Mark M Spiecker | 1 | 1 |
| Carol M Lewis | 1 | 1 |
| Chet M Kaczor | 1 | 1 |
| Dan M Seff | 1 | 1 |
| Brad M Hauert | 1 | 1 |
| Jeffrey L Hval | 1 | 1 |
| Paul M Jenny | 1 | 1 |
| Abram M Gordon | 1 | 1 |
| Jerrod M Milton | 1 | 1 |
| Steven M Summer | 1 | 1 |
| DONNA M LYNNE | 1 | 1 |
| STEPHEN M DAVIS | 1 | 1 |
| Mark W. Spiecker | 1 | 1 |
| Jeffrey W. Hval | 1 | 1 |
| Dan W. Seff | 1 | 1 |
| Mark Spiecker | 1 | 1 |
| Greg B. Carlisle | 1 | 1 |
| Anthony B. Brennan | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.